Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Pine Labs share price screener, Pine Labs share price history, Why Pine Labs share price falling, Pine Labs IPO price, Pine Labs share price NSE today, Pine Labs share price live, and much more. Furthermore, this page provides details on Pine Labs‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Pine Labs Company Information
| Industry | Fintech |
| Founded | 1998; 28 years ago |
| Founders | Lokvir Kapoor Rajul Garg |
| Headquarters | Noida, Uttar Pradesh, India |
| Number of employees | 4,465 (2025) |
| Key people | Lokvir Kapoor (Executive chairman) B. Amrish Rau (CEO)S |
Pine Labs Share Price Target Overview
- Current Price – 142.05
- Open – 142.30
- High – 143.90
- Low – 142.00
- Mkt cap – 16.32KCr
- P/E ratio – 139.33
- 52-wk high – 284.00
- 52-wk low – 134.73
- Dividend – N/A
- Qtrly div amt – N/A
Pine Labs Share Price Chart
Pine Labs Share Price Target Tomorrow (Prediction)
| Pine Labs Share Price Target Years | Pine Labs Share Price Target |
| 2026 | ₹300 |
| 2027 | ₹540 |
| 2028 | ₹680 |
| 2029 | ₹860 |
| 2030 | ₹1040 |
Pine Labs Share Price Target 2026
The target for Pine Labs’s share price in 2026 is projected to range between ₹290 and ₹300. As of the start of June 2026, Pine Labs’s share price stood at ₹142.05. Compared to the previous year, Pine Labs’s share price has witnessed an decrease this year.
Pine Labs Share Price Target 2027
The target for Pine Labs’s share price in 2027 is projected to range between ₹530 and ₹540. On 02 June 2026, Pine Labs Share price NSE is 142.05 INR. Compared to last year, no significant difference has been observed in the share price of Pine Labs. The share price has decreased by approximately 105-110 rupees.
Pine Labs Share Price Target 2030
The target for Pine Labs’s share price in 2030 is projected to range between ₹1030 and ₹1040. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Sudeep Pharma Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Pine Labs Shareholding Pattern
| Promoter | 0% |
| FII | 76.83% |
| DII | 2.92% |
| Retails & Others | 11.36% |
| Mutual Funds | 8.88% |
Income Statement Of Pine Labs
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
6.16B
|
6.50B
|
7.44B
|
7.01B
|
|
Cost of goods sold
|
4.32B
|
4.20B
|
4.57B
|
4.34B
|
|
Cost of revenue
|
4.32B
|
4.20B
|
4.57B
|
4.34B
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
157.77M
|
–
|
–
|
–
|
|
Operating expense
|
2.05B
|
2.19B
|
2.22B
|
2.29B
|
|
Total operating expenses
|
6.36B
|
6.39B
|
6.79B
|
6.62B
|
|
Operating income
|
-201.90M
|
106.70M
|
648.20M
|
381.90M
|
|
Other non operating income
|
-3.09M
|
230.10M
|
354.50M
|
409.30M
|
|
EBT including unusual items
|
-48.49M
|
111.60M
|
625.50M
|
684.10M
|
|
EBT excluding unusual items
|
-303.17M
|
123.40M
|
757.40M
|
621.30M
|
|
Income tax expense
|
-96.35M
|
51.90M
|
201.60M
|
90.50M
|
|
Effective tax rate
|
198.70%
|
46.51%
|
32.23%
|
13.23%
|
|
Other operating expenses
|
1.10B
|
1.43B
|
1.45B
|
1.44B
|
|
Net income
|
47.86M
|
59.70M
|
423.90M
|
593.60M
|
|
Net profit margin
|
0.78%
|
0.92%
|
5.70%
|
8.47%
|
|
Earnings per share
|
–
|
–
|
0.45
|
0.44
|
|
Interest and investment income
|
48.32M
|
–
|
–
|
–
|
|
Interest expense
|
-205.66M
|
-212.70M
|
-244.90M
|
-169.50M
|
|
Net interest expenses
|
-157.34M
|
-212.70M
|
-244.90M
|
-169.50M
|
|
Depreciation and amortization charges
|
652.42M
|
658.70M
|
681.30M
|
708.90M
|
|
EBITDA
|
233.90M
|
982.00M
|
1.52B
|
1.06B
|
|
Gain or loss from assets sale
|
-1.86M
|
-740.00K
|
–
|
–
|
Read Also:- Corona Remedies Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.